Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. Lipid Luminations

The Latest Targets of Lipid Therapy

ReachMD Healthcare Image
Restart
Resume
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Comments
  • Overview

    Host Dr. Larry Kaskel welcomes Dr. Alan Brown, medical director of the Midwest Heart Disease Prevention Center in Naperville, Illinois, to discuss targets of lipid therapy. What are the calculated risk assessments for major cardiovascular events among patients with coronary disease, diabetes and other common risk factors? In these cases, when are statin therapies not enough to provide optimal care? Dr. Brown also opines on the value of residual risk measurements.

    Brought to you by:

    NLA logo

     

Recommended
Details
Presenters
Comments
  • Overview

    Host Dr. Larry Kaskel welcomes Dr. Alan Brown, medical director of the Midwest Heart Disease Prevention Center in Naperville, Illinois, to discuss targets of lipid therapy. What are the calculated risk assessments for major cardiovascular events among patients with coronary disease, diabetes and other common risk factors? In these cases, when are statin therapies not enough to provide optimal care? Dr. Brown also opines on the value of residual risk measurements.

    Brought to you by:

    NLA logo

     

Schedule22 Nov 2024